Compare EVH & CION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVH | CION |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Finance/Investors Services |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 468.7M | 527.0M |
| IPO Year | 2015 | N/A |
| Metric | EVH | CION |
|---|---|---|
| Price | $3.99 | $9.70 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 14 | 1 |
| Target Price | ★ $12.25 | $8.50 |
| AVG Volume (30 Days) | ★ 2.9M | 429.7K |
| Earning Date | 02-19-2026 | 11-06-2025 |
| Dividend Yield | N/A | ★ 15.11% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.49 |
| Revenue | ★ $2,054,052,000.00 | $244,923,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $27.92 | N/A |
| P/E Ratio | ★ N/A | $20.05 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.50 | $8.51 |
| 52 Week High | $12.98 | $12.71 |
| Indicator | EVH | CION |
|---|---|---|
| Relative Strength Index (RSI) | 39.58 | 47.46 |
| Support Level | $3.86 | $9.43 |
| Resistance Level | $4.07 | $9.93 |
| Average True Range (ATR) | 0.17 | 0.18 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 37.63 | 36.49 |
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.